Kihyun Lee
Kihyun Lee has a total of 42 co-authors. Here are the top co-authors by number of shared publications:
- Gun-Ha Kim
Department of Pediatrics, Korea University College of Medicine, Seoul, Korea
2 shared publications - Hyun-Seok Oh
CJ Bioscience, Inc., Seoul, Republic of Korea
2 shared publications - Jongsik Chun
Interdisciplinary Program in Bioinformatics, Seoul National University, Seoul, Republic of Korea
2 shared publications - Jung Ok Shim
Department of Pediatrics, Seoul National University College of Medicine, Seoul, Korea
2 shared publications - Mauricio Chalita
Interdisciplinary Program in Bioinformatics, Seoul National University, Seoul 08826, Korea
2 shared publications - Sein Park
Interdisciplinary Program in Bioinformatics, Seoul National University, Seoul, 08826, Republic of Korea
2 shared publications
Latest Publications
- Open Access
Genome-Level Hierarchical Attention Transformer with Multi-Head Attention Weighted Sum for Broad-Spectrum Antimicrobial Resistance Prediction and Discovery of Resistance-Related Genomic Contexts
Antimicrobial resistance is a growing global health concern, requiring reliable tools for predicting resistance across a wide range of bacteria and antibiotics. In this study, we introduce a genome-level hierarchical attention transformer (GL-HAT) that integrates a pretrained genomic foundation model with hierarchical attention mechanisms to analyze the full protein sequence context of bacterial genomes. GL-HAT is designed to deliver both accurate resistance predictions and interpretable insights into the genomic features associated with resistance using specialized modules. Trained and validated on a comprehensive dataset of bacterial genomes and antimicrobial susceptibility profiles, the model outperformed traditional machine learning method, with an F1-score of 0.845 and AUROC of 0.953. Moreover, GL-HAT could demonstrate the resistance-related contexts in the genome, such as vanA operon and nearby resolvase genes in vancomycin-resistant Enterococcus and tet(M) gene adjacent to conjugation proteins in tetracycline-resistant Streptococcus pneumoniae. By combining high accuracy with interpretability, GL-HAT offers a practical approach for advancing AMR diagnostics and research, supporting more informed clinical and public health decisions.
Open AccessGenome-Level Hierarchical Attention Transformer with Multi-Head Attention Weighted Sum for Broad-Spectrum Antimicrobial Resistance Prediction and Discovery of Resistance-Related Genomic Contexts
Antimicrobial resistance is a growing global health concern, requiring reliable tools for predicting resistance across a wide range of bacteria and antibiotics. In this study, we introduce a genome-level hierarchical attention transformer (GL-HAT) that integrates a pretrained genomic foundation model with hierarchical attention mechanisms to analyze the full protein sequence context of bacterial genomes. GL-HAT is designed to deliver both accurate resistance predictions and interpretable insights into the genomic features associated with resistance using specialized modules. Trained and validated on a comprehensive dataset of bacterial genomes and antimicrobial susceptibility profiles, the model outperformed traditional machine learning method, with an F1-score of 0.845 and AUROC of 0.953. Moreover, GL-HAT could demonstrate the resistance-related contexts in the genome, such as vanA operon and nearby resolvase genes in vancomycin-resistant Enterococcus and tet(M) gene adjacent to conjugation proteins in tetracycline-resistant Streptococcus pneumoniae. By combining high accuracy with interpretability, GL-HAT offers a practical approach for advancing AMR diagnostics and research, supporting more informed clinical and public health decisions.
- Top Cited PapersOpen Access
- 18 June 2024
- Published by Microbiology Society in International Journal of Systematic and Evolutionary Microbiology
- Vol. 74 (6) , 006421
EzBioCloud: a genome-driven database and platform for microbiome identification and discovery
With the continued evolution of DNA sequencing technologies, the role of genome sequence data has become more integral in the classification and identification of Bacteria and Archaea. Six years after introducing EzBioCloud, an integrated platform representing the taxonomic hierarchy of Bacteria and Archaea through quality-controlled 16S rRNA gene and genome sequences, we present an updated version, that further refines and expands its capabilities. The current update recognizes the growing need for accurate taxonomic information as defining a species increasingly relies on genome sequence comparisons. We also incorporated an advanced strategy for addressing underrepresented or less studied lineages, bolstering the comprehensiveness and accuracy of our database. Our rigorous quality control protocols remain, where whole-genome assemblies from the NCBI Assembly Database undergo stringent screening to remove low-quality sequence data. These are then passed through our enhanced identification bioinformatics pipeline which initiates a 16S rRNA gene similarity search and then calculates the average nucleotide identity (ANI). For genome sequences lacking a 16S rRNA sequence and without a closely related genomic representative for ANI calculation, we apply a different ANI approach using bacterial core genes for improved taxonomic placement (core gene ANI, cgANI). Because of the increase in genome sequences available in NCBI and our newly introduced cgANI method, EzBioCloud now encompasses a total of 109 835 species, of which 21 964 have validly published names. 47 896 are candidate species identified either through 16S rRNA sequence similarity (phylotypes) or through whole genome ANI (genomospecies), and the remaining 39 975 were positioned in the taxonomic tree by cgANI (species clusters). Our EzBioCloud database is accessible at www.ezbiocloud.net/db.
- 18 June 2024
- Published by Microbiology Society in International Journal of Systematic and Evolutionary Microbiology
- Vol. 74 (6) , 006421
Top Cited PapersOpen AccessEzBioCloud: a genome-driven database and platform for microbiome identification and discovery
With the continued evolution of DNA sequencing technologies, the role of genome sequence data has become more integral in the classification and identification of Bacteria and Archaea. Six years after introducing EzBioCloud, an integrated platform representing the taxonomic hierarchy of Bacteria and Archaea through quality-controlled 16S rRNA gene and genome sequences, we present an updated version, that further refines and expands its capabilities. The current update recognizes the growing need for accurate taxonomic information as defining a species increasingly relies on genome sequence comparisons. We also incorporated an advanced strategy for addressing underrepresented or less studied lineages, bolstering the comprehensiveness and accuracy of our database. Our rigorous quality control protocols remain, where whole-genome assemblies from the NCBI Assembly Database undergo stringent screening to remove low-quality sequence data. These are then passed through our enhanced identification bioinformatics pipeline which initiates a 16S rRNA gene similarity search and then calculates the average nucleotide identity (ANI). For genome sequences lacking a 16S rRNA sequence and without a closely related genomic representative for ANI calculation, we apply a different ANI approach using bacterial core genes for improved taxonomic placement (core gene ANI, cgANI). Because of the increase in genome sequences available in NCBI and our newly introduced cgANI method, EzBioCloud now encompasses a total of 109 835 species, of which 21 964 have validly published names. 47 896 are candidate species identified either through 16S rRNA sequence similarity (phylotypes) or through whole genome ANI (genomospecies), and the remaining 39 975 were positioned in the taxonomic tree by cgANI (species clusters). Our EzBioCloud database is accessible at www.ezbiocloud.net/db.
- Top Cited PapersOpen Access
- 2 March 2023
- Published by Springer Nature in Nature Communications
- Vol. 14 (1) , 1-19
Population-level impacts of antibiotic usage on the human gut microbiome
The widespread usage of antimicrobials has driven the evolution of resistance in pathogenic microbes, both increased prevalence of antimicrobial resistance genes (ARGs) and their spread across species by horizontal gene transfer (HGT). However, the impact on the wider community of commensal microbes associated with the human body, the microbiome, is less well understood. Small-scale studies have determined the transient impacts of antibiotic consumption but we conduct an extensive survey of ARGs in 8972 metagenomes to determine the population-level impacts. Focusing on 3096 gut microbiomes from healthy individuals not taking antibiotics we demonstrate highly significant correlations between both the total ARG abundance and diversity and per capita antibiotic usage rates across ten countries spanning three continents. Samples from China were notable outliers. We use a collection of 154,723 human-associated metagenome assembled genomes (MAGs) to link these ARGs to taxa and detect HGT. This reveals that the correlations in ARG abundance are driven by multi-species mobile ARGs shared between pathogens and commensals, within a highly connected central component of the network of MAGs and ARGs. We also observe that individual human gut ARG profiles cluster into two types or resistotypes. The less frequent resistotype has higher overall ARG abundance, is associated with certain classes of resistance, and is linked to species-specific genes in the Proteobacteria on the periphery of the ARG network.
- 2 March 2023
- Published by Springer Nature in Nature Communications
- Vol. 14 (1) , 1-19
Top Cited PapersOpen AccessPopulation-level impacts of antibiotic usage on the human gut microbiome
The widespread usage of antimicrobials has driven the evolution of resistance in pathogenic microbes, both increased prevalence of antimicrobial resistance genes (ARGs) and their spread across species by horizontal gene transfer (HGT). However, the impact on the wider community of commensal microbes associated with the human body, the microbiome, is less well understood. Small-scale studies have determined the transient impacts of antibiotic consumption but we conduct an extensive survey of ARGs in 8972 metagenomes to determine the population-level impacts. Focusing on 3096 gut microbiomes from healthy individuals not taking antibiotics we demonstrate highly significant correlations between both the total ARG abundance and diversity and per capita antibiotic usage rates across ten countries spanning three continents. Samples from China were notable outliers. We use a collection of 154,723 human-associated metagenome assembled genomes (MAGs) to link these ARGs to taxa and detect HGT. This reveals that the correlations in ARG abundance are driven by multi-species mobile ARGs shared between pathogens and commensals, within a highly connected central component of the network of MAGs and ARGs. We also observe that individual human gut ARG profiles cluster into two types or resistotypes. The less frequent resistotype has higher overall ARG abundance, is associated with certain classes of resistance, and is linked to species-specific genes in the Proteobacteria on the periphery of the ARG network.
- Open Access
- 14 February 2023
- Published by American Society for Microbiology in Microbiology Spectrum
- Vol. 11 (1) , e0212522
Gut Bacterial Dysbiosis in Irritable Bowel Syndrome: a Case-Control Study and a Cross-Cohort Analysis Using Publicly Available Data Sets
Research on the gut bacteria in irritable bowel syndrome (IBS) shows discordant results due to inconsistent study designs or small sample sizes. To overcome these issues, we analyzed microbiota of 567 IBS patients and 487 healthy people from 10 shared data sets using a unified method.
- 14 February 2023
- Published by American Society for Microbiology in Microbiology Spectrum
- Vol. 11 (1) , e0212522
Open AccessGut Bacterial Dysbiosis in Irritable Bowel Syndrome: a Case-Control Study and a Cross-Cohort Analysis Using Publicly Available Data Sets
Research on the gut bacteria in irritable bowel syndrome (IBS) shows discordant results due to inconsistent study designs or small sample sizes. To overcome these issues, we analyzed microbiota of 567 IBS patients and 487 healthy people from 10 shared data sets using a unified method.
- 29 June 2022
- Published by Springer Nature in Journal of the Korean Physical Society
- Vol. 81 (2) , 126-132
Investigation of the effect of pre-fill gas in VEST discharges by predictive transport simulations
- 29 June 2022
- Published by Springer Nature in Journal of the Korean Physical Society
- Vol. 81 (2) , 126-132
Investigation of the effect of pre-fill gas in VEST discharges by predictive transport simulations
- Open Access
- 1 January 2021
- Published by XMLink in Journal of Korean Medical Science
- Vol. 36 (4) , e38
Epidemiologic Linkage of COVID-19 Outbreaks at Two University-affiliated Hospitals in the Seoul Metropolitan Area in March 2020
Park K, et al. J Korean Med Sci. 2021 Jan;36(4):e38. https://doi.org/10.3346/jkms.2021.36.e38
- 1 January 2021
- Published by XMLink in Journal of Korean Medical Science
- Vol. 36 (4) , e38
Open AccessEpidemiologic Linkage of COVID-19 Outbreaks at Two University-affiliated Hospitals in the Seoul Metropolitan Area in March 2020
Park K, et al. J Korean Med Sci. 2021 Jan;36(4):e38. https://doi.org/10.3346/jkms.2021.36.e38
- Open Access
- 22 December 2020
- Published by MDPI AG in Journal of Clinical Medicine
- Vol. 10 (1) , 5
Gut Bacterial Dysbiosis in Children with Intractable Epilepsy
A few published clinical studies have evaluated the association between gut microbiota in intractable epilepsy, but with inconsistent results. We hypothesized that the factors associated with the gut bacterial composition, such as age and geography, contributed to the discrepancies. Therefore, we used a cohort that was designed to minimize the effects of possible confounding factors and compared the gut microbiota between children with intractable epilepsy and healthy controls. Eight children with intractable epilepsy aged 1 to 7 years and 32 age-matched healthy participants were included. We collected stool samples and questionnaires on their diet and bowel habits at two time points and analyzed the gut microbiota compositions. In the epilepsy group, the amount of Bacteroidetes was lower (Mann–Whitney test, false discovery rate (FDR) < 0.01) and the amount of Actinobacteria was higher (FDR < 0.01) than in the healthy group. The epilepsy subjects were 1.6- to 1.7-fold lower in microbiota richness indices (FDR < 0.01) and harbored a distinct species composition (p < 0.01) compared to the healthy controls. Species biomarkers for intractable epilepsy included the Enterococcus faecium group, Bifidobacterium longum group, and Eggerthella lenta, while the strongest functional biomarker was the ATP-binding cassette (ABC) transporter. Our study identified gut bacterial dysbiosis associated with intractable epilepsy within the cohort that was controlled for the factors that could affect the gut microbiota.
- 22 December 2020
- Published by MDPI AG in Journal of Clinical Medicine
- Vol. 10 (1) , 5
Open AccessGut Bacterial Dysbiosis in Children with Intractable Epilepsy
A few published clinical studies have evaluated the association between gut microbiota in intractable epilepsy, but with inconsistent results. We hypothesized that the factors associated with the gut bacterial composition, such as age and geography, contributed to the discrepancies. Therefore, we used a cohort that was designed to minimize the effects of possible confounding factors and compared the gut microbiota between children with intractable epilepsy and healthy controls. Eight children with intractable epilepsy aged 1 to 7 years and 32 age-matched healthy participants were included. We collected stool samples and questionnaires on their diet and bowel habits at two time points and analyzed the gut microbiota compositions. In the epilepsy group, the amount of Bacteroidetes was lower (Mann–Whitney test, false discovery rate (FDR) < 0.01) and the amount of Actinobacteria was higher (FDR < 0.01) than in the healthy group. The epilepsy subjects were 1.6- to 1.7-fold lower in microbiota richness indices (FDR < 0.01) and harbored a distinct species composition (p < 0.01) compared to the healthy controls. Species biomarkers for intractable epilepsy included the Enterococcus faecium group, Bifidobacterium longum group, and Eggerthella lenta, while the strongest functional biomarker was the ATP-binding cassette (ABC) transporter. Our study identified gut bacterial dysbiosis associated with intractable epilepsy within the cohort that was controlled for the factors that could affect the gut microbiota.